TECX Relative Valuation - AVROBIO Inc - Alpha Spread

AVROBIO Inc
NASDAQ:TECX

Watchlist Manager
AVROBIO Inc Logo
AVROBIO Inc
NASDAQ:TECX
Watchlist
Price: 17.99 USD 2.8%
Market Cap: 265m USD
Have any thoughts about
AVROBIO Inc?
Write Note

Relative Value

There is not enough data to reliably calculate the relative value of TECX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TECX Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
23.9
Forward
-3.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
22.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
24
vs History
1
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.1
Forward
-1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
4.7
Forward
-1.4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
6.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
4.7
vs History
1
vs Industry
Median 3Y
0
Median 5Y
0
Industry
4.7

Multiples Across Competitors

TECX Competitors Multiples
AVROBIO Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
AVROBIO Inc
NASDAQ:TECX
265.1m USD 0 -4.6 -1.5 -1.4
US
Abbvie Inc
NYSE:ABBV
344.8B USD 6.3 65.1 15.9 24.3
US
Amgen Inc
NASDAQ:AMGN
180B USD 5.8 57.5 20.1 36.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
128.6B USD 9.5 29.7 26.1 28.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126B USD 12.2 -257.1 27.4 28.7
US
Epizyme Inc
F:EPE
94.1B EUR 1 967.1 -502 -546.6 -532
US
Gilead Sciences Inc
NASDAQ:GILD
103.2B USD 3.7 97.9 9.3 11.8
AU
CSL Ltd
ASX:CSL
143.4B AUD 6.5 36.4 22.3 27.7
US
Seagen Inc
F:SGT
39.3B EUR 18.9 -58.1 -62.5 -56.4
US
Palatin Technologies Inc
LSE:0KF3
40.1B USD 6 792.6 -1 219.7 -1 236.1 -1 223.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
34.6B USD 14.8 -474.5 208.7 321.3
P/E Multiple
Earnings Growth
US
AVROBIO Inc
NASDAQ:TECX
Average P/E: 57.3
Negative Multiple: -4.6
N/A
US
Abbvie Inc
NYSE:ABBV
65.1
406%
US
Amgen Inc
NASDAQ:AMGN
57.5
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.7
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -257.1
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
97.9
71%
AU
CSL Ltd
ASX:CSL
36.4
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.1 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 219.7 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -474.5 N/A
EV/EBITDA Multiple
EBITDA Growth
US
AVROBIO Inc
NASDAQ:TECX
Average EV/EBITDA: 47.1
Negative Multiple: -1.5
N/A
US
Abbvie Inc
NYSE:ABBV
15.9
28%
US
Amgen Inc
NASDAQ:AMGN
20.1
57%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
26.1
47%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.4
39%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -546.6 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
9.3
10%
AU
CSL Ltd
ASX:CSL
22.3
45%
US
S
Seagen Inc
F:SGT
Negative Multiple: -62.5 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 236.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
208.7
N/A
EV/EBIT Multiple
EBIT Growth
US
AVROBIO Inc
NASDAQ:TECX
Average EV/EBIT: 68.5
Negative Multiple: -1.4
N/A
US
Abbvie Inc
NYSE:ABBV
24.3
86%
US
Amgen Inc
NASDAQ:AMGN
36.5
95%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
28.9
49%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.7
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -532 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
11.8
26%
AU
CSL Ltd
ASX:CSL
27.7
59%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.4 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 223.4 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
321.3
N/A

See Also

Discover More
Back to Top